Reply to “Anti-cytokeratin CAM5.2 Recognized CK8 Mainly, but not CK18: Comment on ‘Early Assessment of Axillary Response with ¹⁸F-FDG PET/CT During Neoadjuvant Chemotherapy in Stage II–III Breast Cancer: Implications for Surgical Management of the Axilla. Ann Surg Oncol. 2013;20(7):2227–35’”

By Koolen Bas   Wesseling Jelle  

Annals of Surgical Oncology, Vol. 21, Iss. 2, 2014-02 ,pp. : 700-700

Springer Publishing Company

Access to resources Recommend Favorite

Comment to “Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and intact primary tumor” by G V Babiera, R Rao, L Feng, F Meric-Bernstam, H M Kuerer, S E Singletary, K K Hunt, M I Ross, K M Gwyn, B W Feig, F C Ames, G N Horthobagyi. Ann Surg Oncol 2006;13:776–782

By Demicheli Romano  

Annals of Surgical Oncology, Vol. 14, Iss. 4, 2007-04 ,pp. : 1519-1520

Springer Publishing Company

Access to resources Recommend Favorite

Anti-cytokeratin CAM5.2 Recognized CK8 Mainly, but not CK18: Comment on “Early Assessment of Axillary Response with ¹⁸F-FDG PET/CT During Neoadjuvant Chemotherapy in Stage II–III Breast Cancer: Implications for Surgical Management of the Axilla. Annals of Surgical Oncology doi: 10.1245/s10434-013-2902-0 (2013)”

By Chao Wan-Ru   Han Chih-Ping  

Annals of Surgical Oncology, Vol. 21, Iss. 2, 2014-02 ,pp. : 699-699

Springer Publishing Company

Access to resources Recommend Favorite

CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression

By Sun Xueqing  

Cancer and Metastasis Reviews, Vol. 29, Iss. 4, 2010-12 ,pp. : 709-722

Springer Publishing Company

Access to resources Recommend Favorite

Editorial About “More than 10-year Follow-up after Total En Bloc Spondylectomy for Spinal Tumors” (doi: 10.1245/s10434-013-3333-7)

By Wolinsky Jean-Paul   Gokaslan Ziya  

Annals of Surgical Oncology, Vol. 21, Iss. 4, 2014-04 ,pp. : 1062-1063

Springer Publishing Company

Access to resources Recommend Favorite